7-6692050-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016265.4(ZNF12):c.892G>A(p.Glu298Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016265.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF12 | ENST00000405858.6 | c.892G>A | p.Glu298Lys | missense_variant | 5/5 | 1 | NM_016265.4 | ENSP00000385939.1 | ||
ZNF12 | ENST00000404360.5 | c.670G>A | p.Glu224Lys | missense_variant | 5/5 | 1 | ENSP00000384405.1 | |||
ZNF12 | ENST00000342651.9 | c.778G>A | p.Glu260Lys | missense_variant | 6/6 | 2 | ENSP00000344745.5 | |||
ENSG00000228010 | ENST00000366167.2 | n.136-16251C>T | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 250328Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135686
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461476Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 727024
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152102Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.892G>A (p.E298K) alteration is located in exon 5 (coding exon 4) of the ZNF12 gene. This alteration results from a G to A substitution at nucleotide position 892, causing the glutamic acid (E) at amino acid position 298 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at